This Albemarle Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded ALB, LQDA, WY, RAL, setting or revising price targets to $130, $70, $25, $88.
Stocks · News reference
What's Going On With Docusign Stock Wednesday?
Docusign (DOCU) stock jumped 2%+, approaching its $75 52-week high despite broader tech declines. Expanded Salesforce deal boosts momentum.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dan Ives Says AI Stock Selloff ‘Opportunity to Own the Winners’: Here Are 7 Companies He Named
In a recent interview, Dan Ives names seven stocks for investors to consider buying with the market pulling back.
Docusign Expands Salesforce Partnership, Making IAM Platform Natively Available To All AI Agents Across Salesforce And Slack
Docusign (NASDAQ:DOCU) today announced the next chapter in its more than 20-year partnership with Salesforce (NYSE:CRM). The expanded partnership brings the Docusign Intelligent Agreement Management (IAM) platform
Netflix, DocuSign And A Health Care Stock On CNBC’s ‘Final Trades’
CNBC traders picked Netflix, AbbVie and DocuSign, citing analyst support, strong momentum, breakthrough designations and a 10% FCF yield.
CNBC Halftime Report Final Trades: AbbVie, DocuSign, Netflix